Bibliographic Details
| Title: |
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection. |
| Authors: |
Mayer, K. A.1, Schrezenmeier, E.2, Diebold, M.1,3, Halloran, P. F.4, Schatzl, M.1, Schranz, S.5, Haindl, S.1, Kasbohm, S.2, Kainz, A.1, Eskandary, F.1, Doberer, K.1, Patel, U. D.6, Dudani, J. S.6, Regele, H.7, Kozakowski, N.7, Kläger, J.7, Boxhammer, R.8, Amann, K.9, Puchhammer-Stöckl, E.10, Vietzen, H.10 |
| Source: |
New England Journal of Medicine. 7/11/2024, Vol. 391 Issue 2, p122-132. 11p. |
| Database: |
Academic Search Ultimate |
